![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, January 06, 2015 3:37:28 AM
http://content.stockpr.com/amarantus/files/pdf/Poster+2+-+Clinical+FINAL_v2.pdf
Some excerpts from the link..
Assay methods:
Sample preparation: Sample preparation for [1] and [2] were as published and similar. In brief, peripheral blood mononuclear cells (PBMC) were isolated from whole heparinized blood samples as described previously [1]. Aliquots of each sample were stimulated with either phytohemaglutinin (PHA, 12 µg/mL), pokeweed mitogen (PWM, 4 µg/mL) or none (Unstimulated) and each cell culture incubated at 37°C with 7% CO2 for four hours [1] and [2] (Version 1 = V1).
The enhanced version (Version 2 = V2) included 8 µg/mL PWM with up to 20 hours incubation.Samples were then diluted and frozen prior to staining for flow cytometry.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM